Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 2Plasma cell 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Waldenstrom Macroglobulinemia 5Sezary Syndrome 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Mycosis Fungoides 5Multiple Myeloma 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, Non-Hodgkin 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Congenital Abnormalities 5Lymphoma, Extranodal NK-T-Cell 4Leukemia, Myeloid, Acute 4Leukemia, Myeloid, Accelerated Phase 4Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Large Granular Lymphocytic 3Leukemia, Hairy Cell 3Intraocular Lymphoma 3Immunoblastic Lymphadenopathy 3Burkitt Lymphoma 3Myeloproliferative Disorders 2Leukemia, Myeloid, Chronic-Phase 2Thrombocythemia, Essential 1

Interventions

Peripheral Blood Stem Cell Transplantation 23Cyclophosphamide 22fludarabine phosphate 19Tacrolimus 17Busulfan 17Antilymphocyte Serum 16Mycophenolic Acid 15Whole-Body Irradiation 13Cyclosporine 13Methotrexate 11Methylprednisolone 10Flow Cytometry 9Therapeutics 7Psychiatric Rehabilitation 7Radiotherapy 6Polymerase Chain Reaction 6Melphalan 6Filgrastim 6Cord Blood Stem Cell Transplantation 6Sirolimus 5Etoposide 5sargramostim 3Ondansetron 3Early Intervention, Educational 3Amplified Fragment Length Polymorphism Analysis 3thymoglobulin 2liposomal amphotericin B 2Voriconazole 2Thiotepa 2Rituximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blast Crisis × Transplantation × Dermatologic × Clear all
NCT01652014 2016-07-14

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Rutgers, The State University of New Jersey

Phase 2 Withdrawn
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡